Email not displaying properly? View email in your browser
Vertical-Talk Healthcare   >  Bioinformatics
>  Generic Combination Products
>  Cold Chain Management
  June 2026   e-Newsletter Advertise | Editorial Calendar | Mediapack  
IQVIA
Latest e-Book
  Expert Talk
  Author Guidelines
  Upcoming Webinars
  Advertorials
  Subscribe
  Event Posting
Advertorials
  Beyond Isolated Risk Scores: Integrating Contamination Controls...
Brent Lieffers explains how the new PDA/ANSI 03‑2025 standard reframes aseptic quality risk management. Moving beyond isolated FMEAs...
Articles
  The Role of Bioinformatics in Accelerating Translational Research
Vasundhara Dauneria, , Biotech Research Scientist
Translational research aims to convert scientific findings into practical clinical solutions, including diagnostics, therapies, and treatment...
  Applying Human Factors Engineering to Generic Combination Products
Frauke Schuurkamp, Managing Human Factors specialist, Emergo by UL
Lisanne de Vogel, Senior Human Factors Specialist, Emergo by UL
When developing a generic combination product, manufacturers can choose to compare their generic combination product to an already...
  Beyond the Cold Chain
Lyophilisation and spray drying as superior biologic platforms
Dr. Mary Manoranjani Addanki, , PhD, Associate Professor and Head of Pharmaceutics, Malla Reddy College of Pharmacy
Valued at US$400.02 billion in 2024, the biologics market is projected to reach US$653.34 billion by 2030 (8.5% CAGR). To mitigate cold-chain...
QPS
News
Engitix and GSK Partner to Identify New Targets...
Everest Medicines Enters into Agreement with...
Techno Trends
 Novo Nordisk Introduced First and Only Awiqli® for Type 2 Diabetes
 Sanofi Introduces Breakthrough Venglustat Therapy for Treating...
 Plixorafenib - A Novel Therapy Introduced for the Treatment of High...
Press Releases
Waters Launches Industry-First Reversed...
Zai Lab Receives China NMPA Approval of...
Projects
 Novo Nordisk to Invest over US$467 Million (€400 Million) in Athlone...
 Vetter Pharma to Invest US$530 million (€480 Million) in Saarlouis...
 AbbVie to Invest US$380 Million in North Chicago, USA
Thermo Fisher Scientific
Events
15 - 18 June, 2026
MedTech Summit 2026
16 - 18 June, 2026
CPHI & PMEC China 2026
24 - 25 June, 2026
Drug Safety Symposium 2026
Research Insights
 Mapping Metabolic Reprogramming in Lung and Breast Cancer...
 Exploring Hypoxia-related Genes as Prognostic Indicators in Lung
 Heterogeneous Biological Graph Convolutional Network for Drug...
Whitepapers
  New EU Pharmaceutical Legislation (Pharma Package)
  Newsletter Subscribe  |  e-book Archives  | Advisory Board
Follow Us Facebook Twitter linkedin
www.pharmafocusasia.com - Owned by Ochre Digi Media Pvt Ltd.
Email: enquiry@pharmafocusasia.com